Other Local Peers |
10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INSMED INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), SEER INC (NASDAQ), ARVINAS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), INSTIL BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MACROGENICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), FIBROGEN INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIOATLA INC (NASDAQ), UNIQURE N.V. (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), IMMUNOGEN INC (NASDAQ), REGENXBIO INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ALLOVIR INC (NASDAQ), ALECTOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), CORTEXYME INC (NASDAQ), OMEROS CORP (NASDAQ), PROTHENA CORP PLC (NASDAQ), CURIS INC (NASDAQ), AFFIMED N V (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HUMANIGEN INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), INHIBRX INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CHIMERIX INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KADMON HLDGS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AGENUS INC (NASDAQ), AKOUOS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), AVROBIO INC (NASDAQ), ALTIMMUNE INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ATRECA INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ADICET BIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CUE BIOPHARMA INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), ONCORUS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), IMMUNOME INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NEXTCURE INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), EVOGENE LTD (NASDAQ), CHIASMA INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), OTONOMY INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), INFLARX N V (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), BIOCARDIA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), GEOVAX LABS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ) |
Other Global Peers |
ARCUS BIOSCIENCES INC (NYSE), 3SBIO (HKEx), KINTOR PHARMA-B (HKEx), JACOBIO-B (HKEx), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), JW THERAP-B (HKEx), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), JHBP-B (HKEx), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), ANTEOTECH LIMITED (ASX), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), SQZ BIOTECHNOLOGIES CO (NYSE), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), ENZO BIOCHEM INC (NYSE), BIOMX INC (NYSE American), CEL-SCI CORP (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), IBIO INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), LEAF RESOURCES LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), UNI-BIO GROUP (HKEx), ACTINOGEN MEDICAL LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City (SGX), ADALTA LTD (ASX), BIOSINO BIO-TEC (HKEx), REGENEUS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX) |